TREATMENT WITH RUXOLITINIB IN COMBINATION WITH EXTRACORPOREAL PHOTOPHERESIS IN STEROID-REFRACTORY ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A SINGLE-CENTRE REAL-WORLD EXPERIENCE

被引：0

作者：

Wais, Verena ^{[1
]}

Gantner, Andrea ^{[1
]}

Weidt, Conrad ^{[1
]}

Neagoie, Adela ^{[1
]}

Schnell, Jacqueline ^{[1
]}

Doehner, Hartmut ^{[1
]}

Bunjes, Donald ^{[1
]}

Sala, Elisa ^{[1
]}

机构：

[1] Univ Hosp Ulm, Ulm, Germany

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P212

引用

页码：297 / 297

页数：1

共 50 条

[21] Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis
Abedin, Sameem
Rashid, Nahid
Schroeder, Mark
Romee, Rizwan
Nauffal, Mary
Moustafa, Muhamad Alhaj
Kharfan-Dabaja, Mohamed A.
Palmer, Jeanne
Hogan, William
Hefazi, Mehrdad
Larson, Samantha
Holtan, Shernan
DeFilipp, Zachariah
Jayani, Reena
Dholaria, Bhagirathbhai
Pidala, Joseph
Khimani, Farhad
Grunwald, Michael R.
Butler, Candace
Hamadani, Mehdi
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 429 - 432
[22] Extracorporeal photopheresis in graft-versus-host disease treatment.: Single-centre experience in 41 refractory chronic GvHD patients
Guídi, S
Guglielmelli, P
D'Ascenzo, G
Lombardini, L
Nozzoli, C
Saccardi, R
Vannucchi, AM
Bosi, A
[J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S131 - S131
[23] Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
Wei, Cong
Zhang, Xiaoting
Liang, Dan
Yang, Jilong
Du, Jingwen
Yue, Chunyan
Deng, Lan
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4875 - 4883
[24] Role of Extracorporeal Photopheresis (ECP) in Treatment of Steroid-Refractory Acute Graft-versus-Host Disease Reply
Pidala, Joseph
Anasetti, Claudio
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1749 - 1749
[25] Ruxolitinib for steroid-refractory acute graft-versus-host disease
Toama, Wael
Fiala, Mark
Pusic, Iskra
Westervelt, Peter
Dipersio, John F.
Schroeder, Mark
[J]. TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
[26] Ruxolitinib in chronic steroid-refractory graft-versus-host-disease.
Kovalenko, Iuliia
Saleem, Tabinda
Laek, Babray
Ali, Rimsha
Mirza, Taaha Muddassir
Chattaraj, Asmi
Wahab, Ahsan
Din, Asma Tamez Ud
Qurashi, Hafiz
Golubykh, Konstantin
Malik, Maidah
Khan, Rafiullah
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[27] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
Moiseev, Ivan
Morozova, Elena
Barabanshikova, Maria
Kozlov, Andrey
Rudakova, Tatyana
Klimova, Olesya
Tcvetkov, Nikolai
Pirogova, Olga
Borzenkova, Evgeniya
Kozhokar, Polina
Ekushev, Kirill
Paina, Olesya
Bykova, Tatyana
Darskaya, Elena
Bondarenko, Sergey
Zubarovskaya, Ludmila
Afanasyev, Boris
[J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
[28] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
Park, Han-Seung
Lee, Je-Hwan
Lee, Jung-Hee
Choi, Eun-Ji
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Lee, Kyoo-Hyung
[J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
[29] Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges
Redondo, Sara
Esquirol, Albert
Novelli, Silvana
Carolina Caballero, Ana
Garrido, Ana
Onate, Guadalupe
Lopez, Jordi
Moreno, Carol
Saavedra, Silvanna-Daniela
Granell, Miquel
Briones, Javier
Sierra, Jorge
Martino, Rodrigo
Garcia-Cadenas, Irene
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 43.e1 - 43.e5
[30] Etanercept for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: a single centre experience in children
Faraci, M.
Giardino, S.
Morreale, G.
Castagnola, E.
Terranova, P.
Di Martino, D.
Lanino, E.
[J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S458 - S459

← 1 2 3 4 5 →